Description
MS346 is an inhibitor of bromodomain BRD4. This compound displays anti-inflammatory activity, decreasing the production of NO and pro-inflammatory cytokines in macrophages.
MS346 is an inhibitor of bromodomain BRD4. This compound displays anti-inflammatory activity, decreasing the production of NO and pro-inflammatory cytokines in macrophages.
Cas No. | 1395084-25-9 |
---|---|
Purity | ≥99% |
Formula | C18H17N5O3S |
Formula Wt. | 383.43 |
IUPAC Name | 4-[(E)-(2-Amino-4-hydroxy-5-methylphenyl)diazenyl]-N-(2-pyridinyl)benzenesulfonamide |
Solubility | 100mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Zhang G, Plotnikov AN, Rusinova E, et al. Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains. J Med Chem. 2013 Nov 27;56(22):9251-64. PMID: 24144283.
CRTH2 inhibitor.
ALK inhibitor.
HDAC6 inhibitor.
Pleuromutilin
Synthetic kahweol derivative.
Toxin produced by Canarthis vesicatoria; PP1/2A...
ALK, ROS1, c-MET inhibitor.
Protein translation inhibitor, peptidyl transfe...
Vitamin E component
Thiazole; proteasome inhibitor, protein translo...
SGLT2 inhibitor
Selective inhibitor of PI3Kβ and PI3Kδ.
Aminoglycoside; protein translation inhibitor.<...
Isoxazole derivative; HSP90 inhibitor.
Fatty acid synthase inhibitor.
Neuraminidase inhibitor.
FAAH inhibitor.
5-HT1A partial agonist, SERT inhibitor.
Impurity of rapamycin